The Clorox Company (CLX)
3 Cheap Stocks Offering Attractive Income
Buy these undervalued dividend stocks that have healthy yields to generate dependable income.
How GOJO Could Shape Clorox's Fiscal 2027 Growth and Margin Outlook
CLX's GOJO deal boosts fiscal 2027 sales, but inflation, acquisition costs and margin pressure could limit underlying growth.
Is Clorox Stock Worth Buying as GOJO Growth Meets Margin Pressure?
CLX's GOJO-led growth faces margin pressure, muted core demand and inflation risks, leaving investors focused on a durable recovery.
Clorox Stock Jumps 13.1% in a Month. Can the Gains Keep Building?
CLX's rebound faces margin pressure, muted underlying demand and weaker earnings revisions despite GOJO and ERP tailwinds.
Clorox: A Better Business, But Too Much Growth Is Priced In
I reiterate a Hold rating on The Clorox Company, as the current valuation requires unsustainably high free cash flow growth. Recent positives include the GOJO acquisition and ERP rollout, but organic revenue growth remains limited after adjusting for these factors. CLX's balance sheet is heavily leveraged post-acquisition, constraining reinvestment and raising dividend sustainability concerns.
Clorox Q4 Earnings & Sales Top Estimates as GOJO Supports Sales
Clorox beats Q4 sales and earnings estimates as GOJO boosts sales, but lower volume and rising costs pressure margins and profits.
CLX Q4 Earnings Call Flags Inflation as Share Recovery Builds
Clorox sees fiscal 2027 sales rising on GOJO and ERP comparisons, but inflation, muted categories and value-seeking consumers cloud the recovery.
The Clorox Company (CLX) Q4 2026 Earnings Call Transcript
The Clorox Company (CLX) Q4 2026 Earnings Call Transcript
Clorox (CLX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Clorox (CLX) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Clorox Q4 Earnings Call Highlights
Clorox NYSE: CLX said it is entering fiscal 2027 with improving market-share trends, a completed enterprise resource planning implementation and a plan to offset more than $200 million in expected supply-chain inflation through productivity initiatives and targeted pricing.
Clorox (CLX) Q4 Earnings and Revenues Surpass Estimates
Clorox (CLX) came out with quarterly earnings of $1.66 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $2.87 per share a year ago.
Clorox Projects Tough Fiscal Year 2027 with Inflation, Value-Seeking Customers
The company now expects sales to rise between 13% and 14% for the current fiscal year after its fourth-quarter revenue fell to $1.95 billion.
